Literature DB >> 21091507

Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activation.

Sandhya V Royan1, Rheinallt M Jones, Athanasia Koutsouris, Jennifer L Roxas, Kanakeshwari Falzari, Andrew W Weflen, Amy Kim, Amy Bellmeyer, Jerrold R Turner, Andrew S Neish, Ki-Jong Rhee, V K Viswanathan, Gail A Hecht.   

Abstract

Enteric bacterial pathogens have evolved sophisticated strategies to evade host immune defences. Some pathogens deliver anti-inflammatory effector molecules into the host cell cytoplasm via a type III secretion system (T3SS). Enteropathogenic Escherichia coli (EPEC) inhibits inflammation by an undefined, T3SS-dependent mechanism. Two proteins encoded outside of the EPEC locus of enterocyte effacement (LEE) pathogenicity island, non-LEE-encoded effector H1 (NleH1) and H2 (NleH2), display sequence similarity to Shigella flexneri OspG, which inhibits activation of the pro-inflammatory transcription factor NF-κB. We hypothesized that the anti-inflammatory effects of EPEC were mediated by NleH1 and NleH2. In this study, we examined the effect of NleH1/H2 on the NF-κB pathway. We show that NleH1/H2 are secreted via the T3SS and that transfection of cells with plasmids harbouring nleH1 or nleH2 decreased IKK-β-induced NF-κB activity and attenuated TNF-α-induced degradation of phospho-IκBα by preventing ubiquitination. Serum KC levels were higher in mice infected with ΔnleH1H2 than those infected with WT EPEC, indicating that NleH1/H2 dampen pro-inflammatory cytokine expression. ΔnleH1H2 was cleared more rapidly than WT EPEC while complementation of ΔnleH1H2 with either NleH1 or NleH2 prolonged colonization. Together, these data show that NleH1 and NleH2 function to dampen host inflammation and facilitate EPEC colonization during pathogenesis.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21091507      PMCID: PMC3325542          DOI: 10.1111/j.1365-2958.2010.07400.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  49 in total

1.  Infectious infantile enteritis, yesterday and today.

Authors:  J Taylor
Journal:  Proc R Soc Med       Date:  1970-12

2.  Mouse model of enteropathogenic Escherichia coli infection.

Authors:  Suzana D Savkovic; Jennilee Villanueva; Jerrold R Turner; Kristina A Matkowskyj; Gail Hecht
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

3.  The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes.

Authors:  Dong Wook Kim; Gerlinde Lenzen; Anne-Laure Page; Pierre Legrain; Philippe J Sansonetti; Claude Parsot
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-14       Impact factor: 11.205

4.  Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo.

Authors:  Donnie E Shifflett; Daniel R Clayburgh; Athanasia Koutsouris; Jerrold R Turner; Gail A Hecht
Journal:  Lab Invest       Date:  2005-10       Impact factor: 5.662

5.  The locus of enterocyte effacement (LEE)-encoded regulator controls expression of both LEE- and non-LEE-encoded virulence factors in enteropathogenic and enterohemorrhagic Escherichia coli.

Authors:  S J Elliott; V Sperandio; J A Girón; S Shin; J L Mellies; L Wainwright; S W Hutcheson; T K McDaniel; J B Kaper
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

6.  Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation.

Authors:  K G Jarvis; J A Girón; A E Jerse; T K McDaniel; M S Donnenberg; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

7.  Regulation of expression and secretion of NleH, a new non-locus of enterocyte effacement-encoded effector in Citrobacter rodentium.

Authors:  Víctor A García-Angulo; Wanyin Deng; Nikhil A Thomas; B Brett Finlay; Jose L Puente
Journal:  J Bacteriol       Date:  2008-01-25       Impact factor: 3.490

8.  Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut.

Authors:  Cordula Hemrajani; Olivier Marches; Siouxsie Wiles; Francis Girard; Alison Dennis; Francis Dziva; Angus Best; Alan D Phillips; Cedric N Berger; Aurelie Mousnier; Valerie F Crepin; Laurens Kruidenier; Martin J Woodward; Mark P Stevens; Roberto M La Ragione; Thomas T MacDonald; Gad Frankel
Journal:  Infect Immun       Date:  2008-08-25       Impact factor: 3.441

9.  Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69.

Authors:  Atsushi Iguchi; Nicholas R Thomson; Yoshitoshi Ogura; David Saunders; Tadasuke Ooka; Ian R Henderson; David Harris; M Asadulghani; Ken Kurokawa; Paul Dean; Brendan Kenny; Michael A Quail; Scott Thurston; Gordon Dougan; Tetsuya Hayashi; Julian Parkhill; Gad Frankel
Journal:  J Bacteriol       Date:  2008-10-24       Impact factor: 3.490

10.  Expression of the chemokine N51/KC in the thymus and epidermis of transgenic mice results in marked infiltration of a single class of inflammatory cells.

Authors:  S A Lira; P Zalamea; J N Heinrich; M E Fuentes; D Carrasco; A C Lewin; D S Barton; S Durham; R Bravo
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more
  36 in total

1.  Determination of spatial and temporal colonization of enteropathogenic E. coli and enterohemorrhagic E. coli in mice using bioluminescent in vivo imaging.

Authors:  Ki-Jong Rhee; Hao Cheng; Antoneicka Harris; Cara Morin; James B Kaper; Gail Hecht
Journal:  Gut Microbes       Date:  2011 Jan-Feb

2.  Expression of enteropathogenic Escherichia coli map is significantly different than that of other type III secreted effectors in vivo.

Authors:  Mai Nguyen; Jason Rizvi; Gail Hecht
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

3.  The Type III Effector NleD from Enteropathogenic Escherichia coli Differentiates between Host Substrates p38 and JNK.

Authors:  Kristina Creuzburg; Cristina Giogha; Tania Wong Fok Lung; Nichollas E Scott; Sabrina Mühlen; Elizabeth L Hartland; Jaclyn S Pearson
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

4.  Inhibition of TLR signaling by a bacterial protein containing immunoreceptor tyrosine-based inhibitory motifs.

Authors:  Dapeng Yan; Xingyu Wang; Lijun Luo; Xuetao Cao; Baoxue Ge
Journal:  Nat Immunol       Date:  2012-09-23       Impact factor: 25.606

5.  A distinct regulatory sequence is essential for the expression of a subset of nle genes in attaching and effacing Escherichia coli.

Authors:  Víctor A García-Angulo; Verónica I Martínez-Santos; Tomás Villaseñor; Francisco J Santana; Alejandro Huerta-Saquero; Luary C Martínez; Rafael Jiménez; Cristina Lara-Ochoa; Juan Téllez-Sosa; Víctor H Bustamante; José L Puente
Journal:  J Bacteriol       Date:  2012-08-17       Impact factor: 3.490

6.  Prolonged NF-κB activation by a macrophage inhibitory cytokine 1-linked signal in enteropathogenic Escherichia coli-infected epithelial cells.

Authors:  Hye Jin Choi; Juil Kim; Kee Hun Do; Seong-Hwan Park; Yuseok Moon
Journal:  Infect Immun       Date:  2013-02-12       Impact factor: 3.441

Review 7.  Bacterial serine/threonine protein kinases in host-pathogen interactions.

Authors:  Marc J Canova; Virginie Molle
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

8.  Identification of a Distinct Substrate-binding Domain in the Bacterial Cysteine Methyltransferase Effectors NleE and OspZ.

Authors:  Ying Zhang; Sabrina Mühlen; Clare V Oates; Jaclyn S Pearson; Elizabeth L Hartland
Journal:  J Biol Chem       Date:  2016-07-21       Impact factor: 5.157

9.  Functional differences and interactions between the Escherichia coli type III secretion system effectors NleH1 and NleH2.

Authors:  Thanh H Pham; Xiaofei Gao; Karen Tsai; Rachel Olsen; Fengyi Wan; Philip R Hardwidge
Journal:  Infect Immun       Date:  2012-03-26       Impact factor: 3.441

Review 10.  In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections.

Authors:  Robyn J Law; Lihi Gur-Arie; Ilan Rosenshine; B Brett Finlay
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.